Education
About Us
Working with TipRanks
Follow Us
Eledon Pharmaceuticals (ELDN)
NASDAQ:ELDN
Tacrolimus, At-1501
Kidney Transplant Rejection
Phase II
Enrolling By Invitation
Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients
Nov 06, 2023
―
Tacrolimus, At-1501
Kidney Transplant Rejection
Phase II
Active Not Recruiting
Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation
Aug 02, 2023
―
At-1501
Prevention Of Rejection In Kidney Transplant
Phase I/II
Recruiting
Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant
Aug 19, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Eledon Pharmaceuticals (ELDN) have in its pipeline
ELDN is currently developing the following drugs: Tacrolimus, At-1501, Tacrolimus, At-1501, At-1501. These drug candidates are in various stages of clinical development as the company works toward FDA approval.